U

ntil recently, the human microbiome languished in relative obscurity. But now it’s drawn all kinds of attention from medicine and from commerce — and three of the field’s star researchers are being recognized for their efforts to advance the field.

“I’m delighted that it’s the microbiome in the spotlight this year,” said Rob Knight, one of this year’s winners of the University of California, San Diego’s prestigious Massry Prize. Knight, a professor and the director of the Center for Microbiome Innovation at UCSD, is sharing the $200,000 prize with Dr. Jeffrey Gordon, a professor at Washington University in St. Louis, and University of Colorado professor Norman Pace; as part of the prize, all will give lectures at the University of Southern California in October.

Unlock this article by subscribing to STAT Plus today. Try it FREE for 30 days and cancel anytime!

SUBSCRIBE TODAY

What is it?

STAT Plus is a premium subscription that delivers daily market-moving biopharma coverage and in-depth science reporting from a team with decades of industry experience.

What's included?

  • Authoritative biopharma coverage and analysis, interviews with industry pioneers, policy analysis, and first looks at cutting edge laboratories and early stage research
  • Subscriber-only networking events and panel discussions across the country
  • Monthly subscriber-only live chats with our reporters and experts in the field
  • Discounted tickets to industry events and early-bird access to industry reports

Leave a Comment

Please enter your name.
Please enter a comment.

  • I should point out thst products used for fecal transplantation are NOT approved by the FDA. They are defined as experimental and thus must be performed under an IND.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy